The LAM assay works best in HIV-infected patients with advanced immunosuppression where it can help diagnose TB and reduce treatment delay [5, 9] but performs very poorly as a diagnostic test in patients with a CD4 count >200 cells/mm3. This evidence concerns the gene CD4 and tuberculosis.